Treatment	Cause	Edge Weight	Shared Publications	PMIDs
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 2: Interplay between Occupational Hazards and Respiratory Mechanics in COPD Pathophysiology	0.08847184986595175	33	33766684|37185038|39011688|36734336|32800204|39435567|36984444|38915126|39914841|33790512|35085029|38989047|39518490|38464331|33419742|32241707|38112122|35062944|38286120|34726941|31969173|38502257|36633864|39717320|34621510|37511692|31928313|37462163|38875850|39379026|38382181|34992358|33806188
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 15: Sleep-Related Pathophysiology and Environmental Exposures in COPD Etiology and Progression	0.037109375	19	40262777|33603356|35717945|33975899|36761857|34741295|38692750|36333077|37353331|34600084|39539251|36057738|32893761|32846806|35216765|38205139|37336060|33596525|37073798
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 3: Environmental and Inflammatory Modulators of Acute COPD Exacerbation Risk and Severity	0.024282560706401765	11	34666820|39391040|34666424|35012620|37225653|31931776|33280252|40241833|32742377|31970968|32746470
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 7: Congenital and Interstitial Lung Diseases as Modifiers of Emphysema and Fibrosis in COPD	0.00998003992015968	5	37487524|37600219|33355081|32384329|32616535
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 35: Cardiovascular and Metabolic Comorbidities as Modifiable Risk Factors for COPD Exacerbation	0.008620689655172414	4	34476248|32499997|39468531|32831978
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 29: Racial and Socioeconomic Disparities in Ambient Air Pollution and COPD Burden	0.006928406466512702	6	32221097|37059160|35017234|36990701|33208303|36948502
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 30: Modulating Bronchial Inflammation in Cystic Fibrosis-Related COPD: Environmental, Genetic, and Therapeutic Interactions	0.005847953216374269	3	35929643|37174791|38202239
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 37: Acute Lung Injury and Inflammatory Dysregulation as Precursors to COPD Progression and Exacerbation	0.005115089514066497	2	33169215|33360048
